{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T05:23:20Z","timestamp":1787289800912,"version":"build-2736575974"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been hypothesized to confer anti-inflammatory, antinociceptive, and anti-addictive benefits. We aimed to investigate their impact on acute perioperative pain and opioid use after total joint arthroplasty (TJA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study analyzed 14,375 hip or knee arthroplasties performed between January 2018 and February 2026, which included 882 patients on chronic preoperative GLP-1RA therapy. Using 1:1 propensity-score matching without replacement, 786 GLP-1RA users were matched to 786 non-users (total n=1,572) based on demographics, surgery type, and chronic medication use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the matched cohort, chronic GLP-1RA use was not associated with reduced inpatient opioid administration (adjusted difference \u22120.18; 95% CI, \u22120.74 to 0.38; p=0.53) or corrected postoperative morphine milligram equivalents (MME) (\u22122.79 MME; 95% CI, \u22126.95 to 1.37; p=0.19). When normalized to hospitalization time, the difference in inpatient opioid exposure was not statistically significant (+0.073 MME\/hour; 95% CI, \u22120.003 to 0.149; p=0.059). Average visual analog scale (VAS) pain scores also showed no significant difference (\u22120.094; p=0.15). However, GLP-1RA users demonstrated a consistently shorter length of stay (LOS) (adjusted difference \u221210.41 hours; 95% CI, \u221213.97 to \u22126.85; p&amp;lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Chronic preoperative GLP-1RA therapy was not associated with reduced inpatient opioid exposure or improved early postoperative pain control following TJA. Nevertheless, GLP-1RA use was consistently associated with shorter hospital LOS. Prospective studies are needed to determine whether this finding reflects improved recovery pathways or residual confounding and to evaluate the impact of GLP-1RAs on longer-term postoperative outcomes and opioid utilization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1918370","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:23:08Z","timestamp":1787286188000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prehospital glucagon-like peptide-1 receptor agonists are not associated with reduced inpatient opioid exposure but with shorter hospital length of stay after total joint arthroplasty"],"prefix":"10.3389","volume":"17","author":[{"given":"Noam","family":"Vaknin","sequence":"first","affiliation":[{"name":"Herzliya Medical Center","place":["Herzliya, Israel"]},{"name":"Cancer Research Center and Wohl Institute for Translational Medicine","place":["Tel Hashomer, Ramat Gan, Israel"]},{"name":"Gray Faculty of Medicine and Health Science, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Seidenberg","sequence":"additional","affiliation":[{"name":"Herzliya Medical Center","place":["Herzliya, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sitton","sequence":"additional","affiliation":[{"name":"Herzliya Medical Center","place":["Herzliya, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Singer","sequence":"additional","affiliation":[{"name":"Herzliya Medical Center","place":["Herzliya, Israel"]},{"name":"Critical Care Medicine and Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital","place":["Petah-Tikva, Israel"]},{"name":"The Research Lab on Computerized Decision Making, School of Medicine, Reichman University","place":["Herzliya, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Mishali","sequence":"additional","affiliation":[{"name":"Herzliya Medical Center","place":["Herzliya, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Vidal","sequence":"additional","affiliation":[{"name":"Herzliya Medical Center","place":["Herzliya, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Slevin-Kish","sequence":"additional","affiliation":[{"name":"Herzliya Medical Center","place":["Herzliya, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22171","article-title":"Diagnosis and treatment of hip and knee osteoarthritis: a review","volume":"325","author":"Katz","year":"2021","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.20.01431","article-title":"An update on multimodal pain management after total joint arthroplasty","volume":"103","author":"Karam","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxab367","article-title":"Persistent postoperative opioid use after total hip or knee arthroplasty: a systematic review and meta-analysis","volume":"79","author":"Tay","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"B5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13075-020-02184-1","article-title":"Predictors of the use of analgesic drugs 1 year after joint replacement: a single-center analysis of 13,000 hip and knee replacements","volume":"22","author":"Rajam\u00e4ki","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01302-0","article-title":"Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions","volume":"21","author":"Karacabeyli","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/phar.70005","article-title":"The potential role of GLP-1 receptor agonists in osteoarthritis","volume":"45","author":"Ryan","year":"2025","journal-title":"Pharmacotherapy"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2026.04.018","article-title":"Anti-inflammatory and anabolic effects of liraglutide on 3D inflammatory osteoarthritic spheroid and scaffold models of human chondrocytes","author":"Ciftci","year":"2026","journal-title":"Osteoarthritis Cartilage"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41598-022-05323-7","article-title":"Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis","volume":"12","author":"Meurot","year":"2022","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10194-025-01979-4","article-title":"Advances in GLP-1 receptor agonists for pain treatment and their future potential","volume":"26","author":"He","year":"2025","journal-title":"J Headache Pain"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-086886","article-title":"Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study","volume":"392","author":"Cai","year":"2026","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2024.3599","article-title":"Repurposing semaglutide and liraglutide for alcohol use disorder","volume":"82","author":"L\u00e4hteenvuo","year":"2024","journal-title":"JAMA Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.arth.2025.09.054","article-title":"The impact of glucagon-like peptide-1 receptor agonist use on clinical outcomes after total hip and knee arthroplasty: a systematic review and meta-analysis of 346,899 patients","volume":"41","author":"Lee","year":"2026","journal-title":"J Arthroplasty"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00223-2","article-title":"Muscle matters: the effects of medically induced weight loss on skeletal muscle","volume":"12","author":"Prado","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2025.08.029","article-title":"ESPEN guideline on clinical nutrition in surgery - Update 2025","volume":"53","author":"Weimann","year":"2025","journal-title":"Clin Nutr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000007967","article-title":"Evaluating the impact of glucagon-like peptide-1 receptor agonist receptor agonists on postoperative pain management in patients undergoing cancer surgery: a retrospective study","author":"Pennycuff","year":"2026","journal-title":"Anesth Analg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000004776","article-title":"ASA consensus-based guidance on preoperative management of patients on glucagon-like peptide-1 receptor agonists","volume":"140","author":"Ushakumari","year":"2024","journal-title":"Anesthesiology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0668-z","article-title":"Pharmacokinetics and clinical implications of semaglutide: a new glucagon-like peptide (GLP)-1 receptor agonist","volume":"57","author":"Hall","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-25-01571","article-title":"Preoperative GLP-1 receptor agonist use and postoperative outcomes in orthopaedic surgery: a scoping review of perioperative and recovery outcomes","volume":"34","author":"Strickler","year":"2026","journal-title":"J Am Acad Orthop Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.35247","article-title":"Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006614","article-title":"Association of perioperative glucagon-like peptide-1 receptor agonist use and postoperative outcomes","volume":"281","author":"Aschen","year":"2025","journal-title":"Ann Surg"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1918370\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:23:09Z","timestamp":1787286189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1918370\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":22,"alternative-id":["10.3389\/fendo.2026.1918370"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1918370","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"article-number":"1918370"}}